These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 36765508)
1. [Clinical Characteristics and Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm]. Zhang XL; Liu B; Li N; Li LK; Ji XJ; Zhou XF; Wang MF; Xu HL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Feb; 31(1):254-260. PubMed ID: 36765508 [TBL] [Abstract][Full Text] [Related]
2. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm. He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300 [TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm. Zhang X; Wu Y; Li C; Shen K; Li R Clin Lab; 2023 Jun; 69(6):. PubMed ID: 37307129 [TBL] [Abstract][Full Text] [Related]
4. [Clinical Characteristics of CD4 He HS; Wei YF; Ji XY; Xu YH; Yang YQ; Jin XK Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):588-594. PubMed ID: 38660871 [TBL] [Abstract][Full Text] [Related]
5. [Blastic plasmacytoid dendritic cell neoplasm: A clinico-pathological retrospective analysis of thirteen cases]. Nong L; Wang W; Liang L; Li D; Li X; Li T Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):308-314. PubMed ID: 37042142 [TBL] [Abstract][Full Text] [Related]
6. [Clinical Analysis of Patients with Blastic Plasmacytoid Dendritic Cell Neoplasm]. Cheng P; Wang QX; Wang LL; Guan J; Zhou Y; Zhang T; Su F; Chen LQ; Cao Y; Cheng H; Zou L Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):896-901. PubMed ID: 37356957 [TBL] [Abstract][Full Text] [Related]
7. [Successful treatment with biweekly CHOP for bone marrow relapse of blastic plasmacytoid dendritic cell neoplasm]. Ono K; Ise M; Ikebe D; Sato A; Wang X; Sugawara T; Tsujimura H; Itami M; Kumagai K Rinsho Ketsueki; 2017; 58(2):150-154. PubMed ID: 28321093 [TBL] [Abstract][Full Text] [Related]
9. Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review. Samhouri Y; Ursu S; Dutton N; Tanvi V; Fazal S J Oncol Pharm Pract; 2021 Jun; 27(4):990-995. PubMed ID: 32847479 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations. Shumilov E; Mazzeo P; Ghandili S; Künstner A; Weidemann S; Banz Y; Ströbel P; Pollak M; Kolloch L; Beltraminelli H; Kerkhoff A; Mikesch JH; Schliemann C; Haase D; Wulf G; Legros M; Lenz G; Feldmeyer L; Pabst T; Witte H; Gebauer N; Bacher U Ann Hematol; 2024 May; 103(5):1587-1599. PubMed ID: 38194088 [TBL] [Abstract][Full Text] [Related]
11. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy. Wilson NR; Konopleva M; Khoury JD; Pemmaraju N Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):734-740. PubMed ID: 34226167 [TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics of 6 patients with blastic plasmacytoid dendritic cell neoplasm]. Han X; Ouyang MQ; Pei Q; Duan MH; Jiang XY; Zhou DB Zhonghua Xue Ye Xue Za Zhi; 2017 Aug; 38(8):700-705. PubMed ID: 28954350 [No Abstract] [Full Text] [Related]
13. [Chemotherapy Combined with Venetoclax Followed by Allo-Hematopoietic Stem Cell Transplantation for Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm]. Cheng P; Wang LL; Wang QX; Guan J; Zhou Y; Hu B; Feng Y; Zou L; Cheng H Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1531-1536. PubMed ID: 37846712 [TBL] [Abstract][Full Text] [Related]
14. [Clinical and Pathological Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm]. Dong F; Zhang ZH; Gao F; Zhen JF; Zheng D; Zhao W; Li M; Jing HM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):518-523. PubMed ID: 32319389 [TBL] [Abstract][Full Text] [Related]
15. [Blastic plasmacytoid dendritic cell neoplasm revealed by ecchymotic lesions on the face]. Ahogo KC; Wantz M; Cliquennois M; Gosset P; Lebas D; Modiano P Ann Dermatol Venereol; 2014 Jan; 141(1):43-7. PubMed ID: 24461094 [TBL] [Abstract][Full Text] [Related]
17. Breakthrough in Blastic Plasmacytoid Dendritic Cell Neoplasm Cancer Therapy Owing to Precision Targeting of CD123. Zanotta S; Galati D; De Filippi R; Pinto A Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338733 [TBL] [Abstract][Full Text] [Related]
18. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity. Lim MS; Lemmert K; Enjeti A BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132 [TBL] [Abstract][Full Text] [Related]
19. [Blastic plasmacytoid dendritic cell neoplasm with complete clinical remission with chemotherapy and central nervous system relapse: Report of one case]. Contreras L; Mercado L; Delgado C; Cabezas C; Starke L; Romero M; Ibieta F; Henríquez M; Chandia M Rev Med Chil; 2017 Jan; 145(1):115-120. PubMed ID: 28393977 [TBL] [Abstract][Full Text] [Related]
20. Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies. Laribi K; Denizon N; Besançon A; Farhi J; Lemaire P; Sandrini J; Truong C; Ghnaya H; Baugier de Materre A Biol Blood Marrow Transplant; 2016 Aug; 22(8):1357-1367. PubMed ID: 27026248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]